イリノイ州における双極性障害の臨床試験
イリノイ州内の拠点で、双極性障害に関する7件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Baber Research Group, Naperville
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
- Revive Research Institute, Elgin
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Revival Research Institute, Elgin
- Advanced Quality Medical Research, Orland Park
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/02更新 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Pillar Clinical Research - Chicago /ID# 272823, Chicago
- Amr Conventions Research /ID# 272867, Warrenville
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/14更新 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research -Chicago, Chicago
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/06/23更新 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。